OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
Ermelinda Lomazzo, Laura Bîndilă, Floortje Remmers, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 2, pp. 488-501
Open Access | Times Cited: 131

Showing 26-50 of 131 citing articles:

Voluntary and evoked behavioral correlates in neuropathic pain states under different social housing conditions
Claudia Pitzer, Rohini Kuner, Anke Tappe‐Theodor
Molecular Pain (2016) Vol. 12
Open Access | Times Cited: 73

The endocannabinoid system in mental disorders: Evidence from human brain studies
Inés Ibarra‐Lecue, Fuencisla Pilar-Cuéllar, Carolina Muguruza, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 97-107
Open Access | Times Cited: 71

Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype
Luis A. Natividad, Matthew W. Buczynski, Melissa A. Herman, et al.
Biological Psychiatry (2017) Vol. 82, Iss. 7, pp. 500-510
Open Access | Times Cited: 70

Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety
Maria Morena, Kira D. Leitl, Haley A. Vecchiarelli, et al.
Neuropharmacology (2016) Vol. 111, pp. 59-69
Closed Access | Times Cited: 67

Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function
Jennifer M. Gray, Christopher Wilson, Tiffany T.-Y. Lee, et al.
Psychoneuroendocrinology (2016) Vol. 66, pp. 151-158
Open Access | Times Cited: 62

Endocannabinoids: Effectors of glucocorticoid signaling
Georgia Balsevich, Gavin N. Petrie, Matthew N. Hill
Frontiers in Neuroendocrinology (2017) Vol. 47, pp. 86-108
Closed Access | Times Cited: 62

Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala
Farhana Yasmin, Roberto Colangeli, Maria Morena, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 117, Iss. 1, pp. 650-655
Open Access | Times Cited: 60

Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie Bourke, Anne Katrin Schlag, Saoirse E. O’Sullivan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108216-108216
Open Access | Times Cited: 28

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
Nicholas S. Adamson Barnes, Vanessa Mitchell, Nicholas P. Kazantzis, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 1, pp. 77-87
Open Access | Times Cited: 61

High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Marie Fitzgibbon, David P. Finn, Michelle Roche
The International Journal of Neuropsychopharmacology (2015) Vol. 19, Iss. 3, pp. pyv095-pyv095
Open Access | Times Cited: 55

Cannabinoid Modulation of the Stressed Hippocampus
Franciele Franco Scarante, Carla Vila-Verde, Vinícius Detoni Lopes, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 55

Sex differences in hippocampal response to endocannabinoids after exposure to severe stress
Tomer Mizrachi Zer‐Aviv, Irit Akirav
Hippocampus (2016) Vol. 26, Iss. 7, pp. 947-957
Closed Access | Times Cited: 53

Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses
Ying Wang, Ning Gu, Tingting Duan, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 2, pp. 215-226
Open Access | Times Cited: 53

Voluntary and evoked behavioral correlates in inflammatory pain conditions under different social housing conditions
Claudia Pitzer, Rohini Kuner, Anke Tappe‐Theodor
PAIN Reports (2016) Vol. 1, Iss. 1, pp. e564-e564
Open Access | Times Cited: 53

Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry
Raissa Lerner, Julia M. Post, Sebastian Loch, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2016) Vol. 1862, Iss. 2, pp. 255-267
Closed Access | Times Cited: 50

Meet Your Stress Management Professionals: The Endocannabinoids
Terri A. deRoon‐Cassini, Todd M. Stollenwerk, Margaret Beatka, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 953-968
Open Access | Times Cited: 48

A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Ming Jiang, Mirjam Huizenga, Jonah L. Wirt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15

The endocannabinoid system as a therapeutic target in neuropathic pain: a review
Manuel Quintero-Castellanos, Luis E. Díaz, Ismael Galve‐Roperh, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 739-755
Closed Access | Times Cited: 4

Visceral Pain in Preterm Infants with Necrotizing Enterocolitis: Underlying Mechanisms and Implications for Treatment
Judith A. ten Barge, Gerbrich E. van den Bosch, Rebeccah Slater, et al.
Pediatric Drugs (2025)
Open Access

Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy
Sina Pakkhesal, Mohammad Shakouri, Reza Mosaddeghi-Heris, et al.
Pharmacology & Therapeutics (2025), pp. 108799-108799
Closed Access

The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs—A practical view
Christopher J. Fowler
European Neuropsychopharmacology (2015) Vol. 25, Iss. 6, pp. 749-762
Closed Access | Times Cited: 47

Scroll to top